posted on 2018-01-15, 17:30authored byAndrew Rosser, Cordula Stover, Manish Pareek, Galina V. Mukamolova
Resuscitation promoting factors (Rpf) are peptidoglycan-hydrolyzing enzymes that are pivotal in the resuscitation of quiescent actinobacteria including Mycobacterium tuberculosis. From the published data, it is clear that Rpf are required for the resuscitation of non-replicating bacilli and pathogenesis in murine infection model of tuberculosis, although their direct influence on human Mycobacterium tuberculosis infection is ill-defined. In this review, we describe the progress in the understanding of the roles that Rpf play in human tuberculosis pathogenesis and importance of bacilli dependent upon Rpf for growth for the outcome of human tuberculosis. We outline how this research is opening up important opportunities for the diagnosis, treatment and prevention of human disease, progress in which is essential to attain the ultimate goal of tuberculosis eradication.
Funding
GVM was funded by Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K000330/1]. AR was supported by a grant [MBE/12005960.1] from the Dowager Countess Eleanor Peel Trust (http://www.peeltrust.com/). MP is supported by the National Institute for Health Research [NIHR Post-Doctoral Fellowship, Dr. Manish Pareek, PDF-2015-08-102].
History
Citation
Critical Reviews in Microbiology, 2017, 43 (5), pp. 621-630
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Infection, Immunity and Inflammation